Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19Ewan C. Goligher, Allen Cheng, Bryan J. McVerry et al.|JAMA|2023Cited by 98
Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trialBrett L. Houston, Ryan Zarychanski, Patrick R. Lawler et al.|Clinical Trials|2020Cited by 68
Continuation of therapeutic dose heparin for critically ill patients with COVID-19Charlotte Bradbury, Edward Litton, Patrick R. Lawler et al.|Intensive Care Medicine|2023Cited by 6